Diseases [C] – Bacterial Infections and Mycoses

The research team at Region Soermland is evaluating topical antimicrobial agents to speed healing of infected wounds, focusing on patients with diabetic foot ulcer. The goal is to determine which local treatments achieve faster closure and reduce the need for hospital care.

  • Topical wound antiseptics
  • Infection control in chronic ulcers
  • Outpatient wound management
  • Healing time assessment

Results are expected to guide community‑based protocols for managing complex skin infections.

Diseases [C] – Cardiovascular Diseases

Investigators are testing whether adding spironolactone or eplerenone to standard therapy can lower hospitalization and cardiovascular death in patients with heart failure with preserved ejection fraction. The study uses a registry‑based design to capture real‑world outcomes.

  • Mineralocorticoid receptor blockade
  • HFpEF patient outcomes
  • Registry‑based randomized trial
  • Cardiovascular event reduction

Findings may reshape treatment guidelines for this growing heart‑failure subgroup.

Diseases [C] – Female Urogenital Diseases and Pregnancy Complications

A comparison is being made between outpatient and inpatient approaches to labour induction to verify safety and effectiveness for expectant mothers. The trial seeks to show that care outside the hospital can be just as reliable.

  • Outpatient induction protocols
  • Maternal and fetal safety metrics
  • Healthcare resource utilization
  • Patient satisfaction

Conducted at Vårdcentralen Centrum Flen, the work could inform national obstetric guidelines.

Diseases [C] – Neoplasms

The centre is assessing whether a coordinated strategy of HPV vaccination and systematic HPV screening can accelerate the elimination of infection and lower rates of cervical cancer among young women.

  • Population‑level vaccination impact
  • Cervical cancer prevention
  • Screening program integration
  • Epidemiological outcomes

The initiative aligns with Sweden’s national cervical screening program and targets women aged 23‑25.

Diseases [C] – Nutritional and Metabolic Diseases

Researchers are comparing early use of a SGLT2‑inhibitor with the traditional metformin regimen to see which better preserves metabolic health in newly diagnosed type 2 diabetes patients.

  • First‑line diabetes therapy
  • Progression‑free survival
  • Metabolic control metrics
  • Long‑term complication risk

Outcomes could influence prescribing practices for early diabetes management.

Diseases [C] – Skin and Connective Tissue Diseases

The trial evaluates two moisturising creams to determine which more effectively prevents relapse of atopic dermatitis, aiming to improve long‑term skin health for patients.

  • Moisturiser comparative effectiveness
  • Eczema relapse timing
  • Patient‑reported symptom relief
  • Daily skin‑care strategies

Findings will support evidence‑based recommendations for routine eczema maintenance.

Psychiatry and Psychology [F] – Mental Disorders

An innovative study is testing whether the immunomodulatory drug rituximab can improve symptoms in adults with schizophrenia spectrum disorder, compared with placebo.

  • Immunotherapy in psychiatry
  • Symptom reduction metrics
  • Placebo‑controlled design
  • Neuroinflammatory mechanisms

Positive results could open new therapeutic avenues for resistant psychotic conditions.